Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen - 40 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1984 adjusted for splits and dividends. The latest closing stock price for Amgen as of April 24, 2024 is 273.01.
  • The all-time high Amgen stock closing price was 322.05 on February 01, 2024.
  • The Amgen 52-week high stock price is 329.72, which is 20.8% above the current share price.
  • The Amgen 52-week low stock price is 211.71, which is 22.5% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 263.19.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 286.5338 295.0931 322.0533 262.7500 273.0100 -4.47%
2023 244.0907 250.9133 286.2321 209.2555 285.7955 13.47%
2022 232.9374 210.7391 278.4880 205.6045 251.8626 20.43%
2021 211.6785 204.3866 235.4246 184.8859 209.1401 0.87%
2020 205.8976 210.7052 232.1817 161.0761 207.3262 -2.00%
2019 170.1339 164.6019 213.4257 144.8753 211.5564 26.70%
2018 159.2089 147.5667 178.6261 139.4555 166.9779 15.17%
2017 140.5080 122.2625 158.1735 122.2625 144.9822 22.25%
2016 124.9861 125.1258 141.4853 108.9377 118.5961 -7.55%
2015 123.7522 123.8440 138.1737 103.9567 128.2789 3.97%
2014 100.6831 87.9966 132.9450 84.6091 123.3792 42.32%
2013 78.3498 66.5115 89.8206 61.2368 86.6934 34.80%
2012 56.5099 46.9361 67.2725 46.6798 64.3106 36.80%
2011 40.7152 40.2491 47.3973 34.9743 47.0093 18.18%
2010 40.3949 41.8180 44.2993 36.4886 39.7781 -2.95%
2009 39.7892 42.7416 46.6686 32.6847 40.9881 -2.04%
2008 37.0547 33.7643 47.7410 28.9605 41.8431 24.35%
2007 41.9695 49.5596 54.9576 33.6484 33.6484 -32.02%
2006 51.1855 58.2253 58.2253 46.3136 49.4944 -13.38%
2005 50.6823 46.5745 62.4350 41.4446 57.1385 22.93%
2004 42.6767 45.1761 47.9873 38.1841 46.4803 3.82%
2003 44.5158 35.7351 51.8347 35.4163 44.7703 27.82%
2002 35.7871 40.8650 45.2703 22.5120 35.0250 -14.35%
2001 45.1503 45.5601 53.7548 37.3219 40.8939 -11.73%
2000 47.4378 45.6035 56.5154 37.1770 46.3281 6.46%
1999 26.8878 19.4543 47.0092 18.9761 43.5168 129.89%
1998 12.1047 9.7706 19.0015 8.5371 18.9290 93.05%
1997 10.0952 9.8955 12.3863 8.3324 9.8051 -0.46%
1996 10.5783 10.5512 11.7738 9.3285 9.8502 -8.42%
1995 7.3832 5.2756 10.7559 5.1171 10.7559 101.29%
1994 4.3852 4.4487 5.3779 3.2025 5.3435 19.19%
1993 3.8084 6.3959 6.4077 2.8529 4.4831 -29.91%
1992 5.8408 6.7700 7.0417 4.5284 6.3959 -6.77%
1991 4.0917 1.9246 6.8605 1.7434 6.8605 265.06%
1990 1.1926 0.7774 1.9131 0.6755 1.8793 154.10%
1989 0.6619 0.4830 0.9057 0.4811 0.7396 45.19%
1988 0.4616 0.4868 0.5396 0.3887 0.5094 8.87%
1987 0.4866 0.3567 0.6717 0.2453 0.4679 40.89%
1986 0.3053 0.1905 0.4284 0.1887 0.3321 62.95%
1985 0.1158 0.0717 0.2189 0.0697 0.2038 169.93%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $146.720B $28.190B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
Vertex Pharmaceuticals (VRTX) United States $104.653B 30.13
Regeneron Pharmaceuticals (REGN) United States $99.589B 24.14
Bristol Myers Squibb (BMY) United States $99.291B 6.53
CSL (CSLLY) Australia $87.672B 0.00
GSK (GSK) United Kingdom $85.467B 10.71
Gilead Sciences (GILD) United States $83.458B 9.97
Moderna (MRNA) United States $41.309B 0.00
Biogen (BIIB) United States $28.081B 13.11
Argenex SE (ARGX) Netherlands $22.291B 0.00
BioNTech SE (BNTX) Germany $21.036B 21.48
Illumina (ILMN) United States $19.821B 143.06
Genmab (GMAB) Denmark $18.885B 24.20
Alnylam Pharmaceuticals (ALNY) United States $18.397B 0.00
BioMarin Pharmaceutical (BMRN) United States $17.375B 73.65
BeiGene (BGNE) Cayman Islands $13.293B 0.00
Incyte (INCY) United States $11.597B 19.27
Exact Sciences (EXAS) United States $11.533B 0.00
Sarepta Therapeutics (SRPT) United States $10.998B 0.00
Bio-Techne Corp (TECH) United States $10.012B 37.25
Repligen (RGEN) United States $9.564B 99.01
QIAGEN (QGEN) Netherlands $9.559B 19.79
Roivant Sciences (ROIV) United Kingdom $8.816B 0.00
Legend Biotech (LEGN) United States $8.632B 0.00
Ascendis Pharma (ASND) Denmark $8.433B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Intra-Cellular Therapies (ITCI) United States $7.165B 0.00
Viking Therapeutics (VKTX) United States $7.156B 0.00
Exelixis (EXEL) United States $6.866B 36.39
Cytokinetics (CYTK) United States $6.857B 0.00
Vaxcyte (PCVX) United States $6.621B 0.00
Apellis Pharmaceuticals (APLS) United States $5.875B 0.00
Blueprint Medicines (BPMC) United States $5.648B 0.00
Halozyme Therapeutics (HALO) United States $4.951B 15.28
CRISPR Therapeutics AG (CRSP) Switzerland $4.788B 0.00
Krystal Biotech (KRYS) United States $4.621B 0.00
Zealand Pharma (ZLDPF) Denmark $4.434B 0.00
Nuvalent (NUVL) United States $4.331B 0.00
Immunovant (IMVT) United States $4.157B 0.00
Alkermes (ALKS) Ireland $4.104B 21.66
Insmed (INSM) United States $3.754B 0.00
ImmunityBio (IBRX) United States $3.717B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.713B 0.00
Biohaven (BHVN) United States $3.496B 0.00
Axsome Therapeutics (AXSM) United States $3.462B 0.00
Iovance Biotherapeutics (IOVA) United States $3.313B 0.00
Fortrea Holdings (FTRE) United States $3.301B 0.00
SpringWorks Therapeutics (SWTX) United States $3.247B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.180B 0.00
Amicus Therapeutics (FOLD) United States $3.164B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.100B 0.00
IDEAYA Biosciences (IDYA) United States $2.917B 0.00
Apogee Therapeutics (APGE) United States $2.909B 0.00
Arcellx (ACLX) United States $2.901B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.855B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.763B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.758B 0.00
MorphoSys AG (MOR) Germany $2.717B 0.00
Certara (CERT) United States $2.680B 57.69
Janux Therapeutics (JANX) United States $2.572B 0.00
CG Oncology (CGON) United States $2.420B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.406B 0.00
Merus (MRUS) Netherlands $2.396B 0.00
Arvinas (ARVN) United States $2.322B 0.00
Denali Therapeutics (DNLI) United States $2.296B 0.00
Vericel (VCEL) United States $2.246B 0.00
Kymera Therapeutics (KYMR) United States $2.182B 0.00
Vera Therapeutics (VERA) United States $2.152B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.142B 0.00
Celldex Therapeutics (CLDX) United States $2.111B 0.00
Guardant Health (GH) United States $2.111B 0.00
Intellia Therapeutics (NTLA) United States $2.076B 0.00
Avidity Biosciences (RNA) United States $2.004B 0.00
Keros Therapeutics (KROS) United States $1.991B 0.00
Galapagos (GLPG) Belgium $1.941B 0.00
Beam Therapeutics (BEAM) United States $1.932B 0.00
Geron (GERN) United States $1.914B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.874B 0.00
Twist Bioscience (TWST) United States $1.821B 0.00
NeoGenomics (NEO) United States $1.808B 0.00
Sana Biotechnology (SANA) United States $1.783B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.782B 0.00
Myriad Genetics (MYGN) United States $1.683B 0.00
Structure Therapeutics (GPCR) United States $1.682B 0.00
Bavarian Nordic (BVNRY) Denmark $1.675B 5.50
Harmony Biosciences Holdings (HRMY) United States $1.638B 13.61
Neumora Therapeutics (NMRA) United States $1.637B 0.00
Inhibrx (INBX) United States $1.618B 0.00
Protagonist Therapeutics (PTGX) United States $1.565B 0.00
Dynavax Technologies (DVAX) United States $1.539B 0.00
Zai Lab (ZLAB) China $1.500B 0.00
ADMA Biologics Inc (ADMA) United States $1.493B 0.00
Edgewise Therapeutics (EWTX) United States $1.457B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.454B 0.00
Akero Therapeutics (AKRO) United States $1.452B 0.00
Morphic Holding (MORF) United States $1.439B 0.00
Kura Oncology (KURA) United States $1.427B 0.00
Arcus Biosciences (RCUS) United States $1.408B 0.00
ANI Pharmaceuticals (ANIP) United States $1.394B 17.14
Gyre Therapeutics (GYRE) United States $1.362B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.260B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.248B 0.00
Spyre Therapeutics (SYRE) United States $1.238B 0.00
Ligand Pharmaceuticals (LGND) United States $1.237B 15.33
Autolus Therapeutics (AUTL) United Kingdom $1.191B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.185B 0.00
AbCellera Biologics (ABCL) Canada $1.162B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.154B 0.00
Scholar Rock Holding (SRRK) United States $1.152B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.148B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.133B 0.00
MannKind (MNKD) United States $1.126B 0.00
Prothena (PRTA) Ireland $1.104B 0.00
Vir Biotechnology (VIR) United States $1.093B 0.00
Belite Bio (BLTE) United States $1.079B 0.00
Abivax SA (ABVX) France $0.998B 0.00
Liquidia Technologies (LQDA) United States $0.985B 0.00
MiMedx (MDXG) United States $0.957B 217.00
Viridian Therapeutics (VRDN) United States $0.894B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.892B 0.00
Immatics (IMTX) Germany $0.882B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.876B 0.00
Immunome (IMNM) United States $0.875B 0.00
Tyra Biosciences (TYRA) United States $0.860B 0.00
89BIO (ETNB) United States $0.849B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.846B 0.00
Tango Therapeutics (TNGX) United States $0.829B 0.00
Kyverna Therapeutics (KYTX) United States $0.827B 0.00
REGENXBIO (RGNX) United States $0.780B 0.00
ALX Oncology Holdings (ALXO) United States $0.775B 0.00
Cytek Biosciences (CTKB) United States $0.760B 0.00
Pliant Therapeutics (PLRX) United States $0.755B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.752B 0.00
CARGO Therapeutics (CRGX) United States $0.748B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.730B 0.00
Cullinan Therapeutics (CGEM) United States $0.718B 0.00
PureTech Health (PRTC) United States $0.706B 0.00
Nurix Therapeutics (NRIX) United States $0.695B 0.00
Dianthus Therapeutics (DNTH) United States $0.687B 0.00
Mesoblast (MESO) Australia $0.684B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.681B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.672B 0.00
Cogent Biosciences (COGT) United States $0.665B 0.00
EnGene Holdings (ENGN) United States $0.665B 0.00
Disc Medicine (IRON) United States $0.652B 0.00
Aerovate Therapeutics (AVTE) United States $0.647B 0.00
Praxis Precision Medicines (PRAX) United States $0.647B 0.00
Pharming Group (PHAR) Netherlands $0.644B 0.00
Cabaletta Bio (CABA) United States $0.643B 0.00
HilleVax (HLVX) United States $0.637B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.623B 0.00
WAVE Life Sciences (WVE) Singapore $0.621B 0.00
Pharming Group (PHGUF) Netherlands $0.620B 0.00
Zymeworks (ZYME) United States $0.604B 0.00
Oric Pharmaceuticals (ORIC) United States $0.591B 0.00
GH Research (GHRS) Ireland $0.588B 0.00
Novavax (NVAX) United States $0.586B 0.00
Nuvation Bio (NUVB) United States $0.584B 0.00
CureVac (CVAC) Germany $0.582B 0.00
Prime Medicine (PRME) United States $0.576B 0.00
Allogene Therapeutics (ALLO) United States $0.570B 0.00
Northwest Biotherapeutics (NWBO) United States $0.568B 0.00
Mineralys Therapeutics (MLYS) United States $0.567B 0.00
Olema Pharmaceuticals (OLMA) United States $0.559B 0.00
Castle Biosciences (CSTL) United States $0.551B 0.00
Absci (ABSI) United States $0.531B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.530B 0.00
Astria Therapeutics (ATXS) United States $0.529B 0.00
ArriVent BioPharma (AVBP) United States $0.528B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Celcuity (CELC) United States $0.525B 0.00
Stoke Therapeutics (STOK) United States $0.521B 0.00
Fate Therapeutics (FATE) United States $0.517B 0.00
AnaptysBio (ANAB) United States $0.513B 0.00
Alector (ALEC) United States $0.511B 0.00
Applied Therapeutics (APLT) United States $0.510B 0.00
Arbutus Biopharma (ABUS) United States $0.494B 0.00
Oculis Holding AG (OCS) Switzerland $0.485B 0.00
C4 Therapeutics (CCCC) United States $0.473B 0.00
Humacyte (HUMA) United States $0.468B 0.00
Fulcrum Therapeutics (FULC) United States $0.462B 0.00
Adlai Nortye (ANL) Cayman Islands $0.460B 0.00
ACELYRIN, INC (SLRN) United States $0.455B 0.00
IGM Biosciences (IGMS) United States $0.453B 0.00
Shattuck Labs (STTK) United States $0.451B 0.00
Third Harmonic Bio (THRD) United States $0.450B 0.00
Editas Medicine (EDIT) United States $0.449B 0.00
Travere Therapeutics (TVTX) United States $0.437B 0.00
Entrada Therapeutics (TRDA) United States $0.433B 0.00
Avid Bioservices (CDMO) United States $0.422B 0.00
Voyager Therapeutics (VYGR) United States $0.415B 2.48
ADC Therapeutics SA (ADCT) Switzerland $0.412B 0.00
Neurogene (NGNE) United States $0.401B 0.00
Annexon (ANNX) United States $0.400B 0.00
MaxCyte (MXCT) United States $0.397B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.396B 0.00
Replimune (REPL) United States $0.394B 0.00
Biomea Fusion (BMEA) United States $0.394B 0.00
ITeos Therapeutics (ITOS) United States $0.394B 0.00
Mersana Therapeutics (MRSN) United States $0.389B 0.00
Anika Therapeutics (ANIK) United States $0.383B 0.00
Revance Therapeutics (RVNC) United States $0.381B 0.00
PepGen (PEPG) United States $0.379B 0.00
Adaptive Biotechnologies (ADPT) United States $0.374B 0.00
Nkarta (NKTX) United States $0.374B 0.00
Alto Neuroscience (ANRO) United States $0.373B 0.00
Amarin (AMRN) Ireland $0.363B 0.00
FibroBiologics (FBLG) United States $0.362B 0.00
Caribou Biosciences (CRBU) United States $0.359B 0.00
Aura Biosciences (AURA) United States $0.357B 0.00
Tenaya Therapeutics (TNYA) United States $0.349B 0.00
Precigen (PGEN) United States $0.348B 0.00
TScan Therapeutics (TCRX) United States $0.348B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.347B 0.00
Solid Biosciences (SLDB) United States $0.345B 0.00
Urogen Pharma (URGN) United States $0.341B 0.00
Rani Therapeutics Holdings (RANI) United States $0.336B 0.00
Jasper Therapeutics (JSPR) United States $0.333B 0.00
Ocugen (OCGN) United States $0.322B 0.00
MeiraGTx Holdings (MGTX) United States $0.317B 0.00
Atea Pharmaceuticals (AVIR) United States $0.314B 0.00
Nautilus Biotechnology (NAUT) United States $0.311B 0.00
Ventyx Biosciences (VTYX) United States $0.307B 0.00
XOMA (XOMA) United States $0.304B 0.00
Terns Pharmaceuticals (TERN) United States $0.303B 0.00
Anavex Life Sciences (AVXL) United States $0.302B 0.00
CorMedix Inc (CRMD) United States $0.299B 0.00
Kamada (KMDA) Israel $0.293B 22.13
Erasca (ERAS) United States $0.292B 0.00
Contineum Therapeutics (CTNM) United States $0.290B 0.00
Renovaro (RENB) United States $0.290B 0.00
Werewolf Therapeutics (HOWL) United States $0.279B 0.00
Rapt Therapeutics (RAPT) United States $0.278B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.278B 0.00
Inozyme Pharma (INZY) United States $0.272B 0.00
Invivyd (IVVD) United States $0.271B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.266B 92.60
Oxford BioMedica (OXBDF) United Kingdom $0.262B 0.00
ChromaDex (CDXC) United States $0.256B 0.00
XBiotech (XBIT) United States $0.249B 0.00
Coherus BioSciences (CHRS) United States $0.247B 0.00
Puma Biotechnology (PBYI) United States $0.247B 11.15
Verastem (VSTM) United States $0.243B 0.00
Inovio Pharmaceuticals (INO) United States $0.242B 0.00
23andMe Holding (ME) United States $0.238B 0.00
2seventy Bio (TSVT) United States $0.238B 0.00
AC Immune (ACIU) Switzerland $0.235B 0.00
Sutro Biopharma (STRO) United States $0.232B 0.00
Adverum Biotechnologies (ADVM) United States $0.228B 0.00
UniQure (QURE) Netherlands $0.227B 0.00
Ovid Therapeutics (OVID) United States $0.226B 0.00
Prima BioMed (IMMP) Australia $0.221B 0.00
G1 Therapeutics (GTHX) United States $0.219B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Elevation Oncology (ELEV) United States $0.210B 0.00
Compass Therapeutics (CMPX) United States $0.209B 0.00
Poseida Therapeutics (PSTX) United States $0.208B 0.00
Design Therapeutics (DSGN) United States $0.207B 0.00
X4 Pharmaceuticals (XFOR) United States $0.207B 0.00
Codexis (CDXS) United States $0.204B 0.00
Trevi Therapeutics (TRVI) United States $0.197B 0.00
Opthea (OPT) Australia $0.196B 0.00
Lifecore Biomedical (LFCR) United States $0.196B 0.00
Innate Pharma S.A (IPHA) France $0.192B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.190B 0.00
Alimera Sciences (ALIM) United States $0.188B 0.00
Akoya Biosciences (AKYA) United States $0.187B 0.00
Cardiff Oncology (CRDF) United States $0.186B 0.00
INmune Bio (INMB) United States $0.185B 0.00
Kodiak Sciences (KOD) United States $0.175B 0.00
Candel Therapeutics (CADL) United States $0.173B 0.00
Skye Bioscience (SKYE) United States $0.173B 0.00
Inventiva S.A (IVA) France $0.173B 0.00
Adicet Bio (ACET) United States $0.173B 0.00
GENFIT S.A (GNFT) France $0.172B 0.00
Compugen (CGEN) Israel $0.172B 0.00
Greenwich LifeSciences (GLSI) United States $0.169B 0.00
Adocia (ADOCY) France $0.169B 0.00
Gossamer Bio (GOSS) United States $0.166B 0.00
ScPharmaceuticals (SCPH) United States $0.166B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.164B 0.00
Scilex Holding (SCLX) United States $0.162B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.162B 0.00
Zura Bio (ZURA) United States $0.150B 0.00
BioStem Technologies (BSEM) $0.150B 0.00
CervoMed (CRVO) United States $0.150B 0.00
Cellectis S.A (CLLS) France $0.146B 0.00
I-Mab (IMAB) China $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.141B 0.00
Syros Pharmaceuticals (SYRS) United States $0.137B 0.00
Sagimet Biosciences (SGMT) United States $0.137B 0.00
Agenus (AGEN) United States $0.135B 0.00
DBV Technologies S.A (DBVT) France $0.131B 0.00
Annovis Bio (ANVS) United States $0.131B 0.00
VistaGen Therapeutics (VTGN) United States $0.131B 0.00
Omega Therapeutics (OMGA) United States $0.129B 0.00
Vor Biopharma (VOR) $0.128B 0.00
Repare Therapeutics (RPTX) Canada $0.124B 0.00
Emergent Biosolutions (EBS) United States $0.120B 0.00
PDS Biotechnology (PDSB) United States $0.117B 0.00
Seer (SEER) United States $0.117B 0.00
Coya Therapeutics (COYA) United States $0.117B 0.00
Nuvectis Pharma (NVCT) United States $0.117B 0.00
Adagene (ADAG) China $0.117B 0.00
Seres Therapeutics (MCRB) United States $0.115B 0.00
Rezolute (RZLT) United States $0.115B 0.00
CytomX Therapeutics (CTMX) United States $0.114B 0.00
Immunic (IMUX) United States $0.112B 0.00
Cartesian Therapeutics (RNAC) United States $0.111B 0.00
TELA Bio (TELA) United States $0.110B 0.00
ATyr Pharma (LIFE) United States $0.110B 0.00
BioXcel Therapeutics (BTAI) United States $0.110B 0.00
Sangamo Therapeutics (SGMO) United States $0.108B 0.00
BioAtla (BCAB) United States $0.108B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
Bluebird Bio (BLUE) United States $0.106B 0.00
BioHarvest Sciences (CNVCF) Canada $0.105B 0.00
Clearside Biomedical (CLSD) United States $0.102B 0.00
Vigil Neuroscience (VIGL) United States $0.100B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.099B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.098B 0.00
IO Biotech (IOBT) Denmark $0.097B 0.00
Elicio Therapeutics (ELTX) United States $0.094B 0.00
Genelux (GNLX) United States $0.093B 0.00
Abeona Therapeutics (ABEO) United States $0.093B 0.00
Allakos (ALLK) United States $0.092B 0.00
DiaMedica Therapeutics (DMAC) United States $0.092B 0.00
Galena Biopharma (SLS) United States $0.092B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.090B 0.00
BeyondSpring (BYSI) United States $0.089B 0.00
Curis (CRIS) United States $0.088B 0.00
Atara Biotherapeutics (ATRA) United States $0.086B 0.00
Eton Pharmaceuticals (ETON) United States $0.084B 0.00
Q32 Bio (QTTB) United States $0.083B 0.00
Leap Therapeutics (LPTX) United States $0.082B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.082B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
Affimed (AFMD) Germany $0.081B 0.00
Aileron Therapeutics (ALRN) United States $0.081B 0.00
InflaRx (IFRX) Germany $0.080B 0.00
Oncolytics Biotech (ONCY) Canada $0.080B 0.00
Athira Pharma (ATHA) United States $0.078B 0.00
Cognition Therapeutics (CGTX) United States $0.078B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.87
Connect Biopharma Holdings (CNTB) United States $0.077B 0.00
Passage Bio (PASG) United States $0.076B 0.00
HOOKIPA Pharma (HOOK) United States $0.076B 0.00
YS Biopharma (YS) China $0.075B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.075B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.074B 0.00
Alpha Teknova (TKNO) United States $0.073B 0.00
Cue Biopharma (CUE) United States $0.073B 0.00
Gritstone Bio (GRTS) United States $0.072B 0.00
Turnstone Biologics (TSBX) United States $0.071B 0.00
Precision BioSciences (DTIL) United States $0.071B 0.00
AN2 Therapeutics (ANTX) United States $0.071B 0.00
Instil Bio (TIL) United States $0.070B 0.00
Elutia (ELUT) United States $0.070B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.069B 0.00
Landos Biopharma (LABP) United States $0.069B 0.00
Genenta Science S.p.A (GNTA) Italy $0.066B 0.00
Rallybio (RLYB) United States $0.066B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.065B 0.00
Entera Bio (ENTX) Israel $0.064B 0.00
Aligos Therapeutics (ALGS) United States $0.062B 0.00
Celularity (CELU) United States $0.062B 0.00
Lantern Pharma (LTRN) United States $0.062B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.062B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
HCW Biologics (HCWB) United States $0.061B 0.00
Equillium (EQ) United States $0.061B 0.00
Kezar Life Sciences (KZR) United States $0.060B 0.00
LENZ Therapeutics (LENZ) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.057B 0.00
Enzo Biochem (ENZ) United States $0.056B 0.00
Intensity Therapeutics (INTS) United States $0.056B 0.00
AVROBIO (AVRO) United States $0.054B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.054B 0.00
ARCA Biopharma (ABIO) United States $0.053B 0.00
Ocean Biomedical (OCEA) United States $0.051B 0.00
Checkpoint Therapeutics (CKPT) United States $0.051B 0.00
CalciMedica (CALC) United States $0.049B 0.00
Quince Therapeutics (QNCX) United States $0.048B 0.00
Immuneering (IMRX) United States $0.048B 0.00
Cidara Therapeutics (CDTX) United States $0.047B 0.00
Aadi Bioscience (AADI) United States $0.045B 0.00
Beyond Air (XAIR) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.043B 0.00
Dyadic (DYAI) United States $0.043B 0.00
Clene (CLNN) United States $0.043B 0.00
Apollomics (APLM) United States $0.043B 0.00
NextCure (NXTC) United States $0.043B 0.00
Carmell (CTCX) United States $0.042B 0.00
Bolt Biotherapeutics (BOLT) United States $0.042B 0.00
NKGen Biotech (NKGN) United States $0.042B 0.00
Prenetics Global (PRE) Cayman Islands $0.042B 0.00
OKYO Pharma (OKYO) $0.040B 0.00
SAB Biotherapeutics (SABS) United States $0.040B 0.00
Promis Neurosciences (PMN) Canada $0.039B 0.00
Cara Therapeutics (CARA) United States $0.039B 0.00
Ocuphire Pharma (OCUP) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
BRIACELL THERAP (BCTX) Canada $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
Fortress Biotech (FBIO) United States $0.035B 0.00
Cyclo Therapeutics (CYTH) United States $0.035B 0.00
Theratechnologies (THTX) Canada $0.033B 0.00
IN8bio (INAB) United States $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Dare Bioscience (DARE) United States $0.030B 0.00
BioAffinity Technologies (BIAF) United States $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
Semper Paratus Acquisition (TVGN) United States $0.026B 0.00
Pluri (PLUR) Israel $0.026B 0.00
Eyenovia (EYEN) United States $0.026B 0.00
Vaxxinity (VAXX) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Biora Therapeutics (BIOR) United States $0.023B 0.00
Lumos Pharma (LUMO) United States $0.023B 0.00
Synlogic (SYBX) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
Galecto (GLTO) Denmark $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.019B 0.00
KALA BIO (KALA) United States $0.018B 0.00
Orgenesis (ORGS) United States $0.018B 0.00
Benitec Biopharma (BNTC) United States $0.018B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.015B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.015B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
ABVC BioPharma (ABVC) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Senti Biosciences (SNTI) United States $0.014B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
Purple Biotech (PPBT) Israel $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Virios Therapeutics (VIRI) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.008B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Chemomab Therapeutics (CMMB) Israel $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Kintara Therapeutics (KTRA) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.32
Longeveron (LGVN) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Biophytis SA (BPTS) France $0.004B 0.00
Invo BioScience (INVO) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.000B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00